IDEXX LABORATORIES INC /DE Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Idexx Laboratories Inc /De quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Idexx Laboratories Inc /De Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $233M, a 9.71% increase year-over-year.
  • Idexx Laboratories Inc /De Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $866M, a 5.29% increase year-over-year.
  • Idexx Laboratories Inc /De annual Net Income (Loss) Attributable to Parent for 2023 was $845M, a 24.4% increase from 2022.
  • Idexx Laboratories Inc /De annual Net Income (Loss) Attributable to Parent for 2022 was $679M, a 8.83% decline from 2021.
  • Idexx Laboratories Inc /De annual Net Income (Loss) Attributable to Parent for 2021 was $745M, a 28% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $866M $233M +$20.6M +9.71% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $846M $203M -$20.9M -9.34% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-31
Q1 2024 $867M $236M +$21.5M +10.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-10-31
Q4 2023 $845M $195M +$22.3M +13% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $823M $212M +$31.3M +17.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $791M $224M +$92.3M +69.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-31
Q1 2023 $699M $214M +$20.1M +10.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-31
Q4 2022 $679M $172M +$9.44M +5.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $670M $181M +$5.7M +3.25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $664M $132M -$70.6M -34.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-01
Q1 2022 $735M $194M -$10.3M -5.04% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-01
Q4 2021 $745M $163M -$12M -6.88% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $757M $175M +$29M +19.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $728M $203M +$53.6M +36% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $674M $204M +$92.4M +82.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $582M $175M +$84.3M +93.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $497M $146M +$37.4M +34.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $460M $149M +$23.2M +18.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $437M $112M +$9.15M +8.91% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $428M $90.5M +$4.86M +5.67% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-14
Q3 2019 $423M $109M +$15.6M +16.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $407M $126M +$17M +15.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $390M $103M +$13.2M +14.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $377M $85.6M +$47.4M +124% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 $330M $93.3M +$22.7M +32.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-14
Q2 2018 $307M $109M +$23.3M +27.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-14
Q1 2018 $284M $89.5M +$20.4M +29.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-14
Q4 2017 $263M $38.3M -$14.1M -26.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-15
Q3 2017 $277M $70.5M +$14.1M +24.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-15
Q2 2017 $263M $85.4M +$18.2M +27% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-15
Q1 2017 $245M $69M +$23M +50% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-15
Q4 2016 $222M $52.4M +$8.02M +18.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 $214M $56.5M +$12.2M +27.7% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-16
Q2 2016 $202M $67.2M +$10.3M +18.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-16
Q1 2016 $192M $46M -$575K -1.23% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-16
Q4 2015 $192M $44.3M +$18.4M +70.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-17
Q3 2015 $174M $44.2M -$7.92M -15.2% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-17
Q2 2015 $182M $56.9M -$306K -0.54% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-17
Q1 2015 $182M $46.6M +$9K +0.02% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-17
Q4 2014 $182M $26M -$17.3M -40% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-17
Q3 2014 $199M $52.1M +$6.45M +14.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-17
Q2 2014 $193M $57.2M +$3.22M +5.97% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-17
Q1 2014 $190M $46.6M +$1.73M +3.85% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-17
Q4 2013 $188M $43.3M -$96K -0.22% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-17
Q3 2013 $188M $45.7M +$2.84M +6.62% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-17
Q2 2013 $185M $54M +$2.68M +5.22% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-17
Q1 2013 $182M $44.9M +$4.12M +10.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-17
Q4 2012 $178M $43.4M +$5.34M +14.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-18
Q3 2012 $173M $42.9M +$4.35M +11.3% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-18
Q2 2012 $169M $51.3M +$2.66M +5.47% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-18
Q1 2012 $166M $40.7M +$4.13M +11.3% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-18
Q4 2011 $162M $38M +$1.64M +4.51% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-19
Q3 2011 $160M $38.5M +$3.81M +11% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-19
Q2 2011 $156M $48.7M +$11.5M +30.8% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-19
Q1 2011 $145M $36.6M +$3.59M +10.9% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-19
Q4 2010 $141M $36.4M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-17
Q3 2010 $34.7M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-17
Q2 2010 $37.2M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-17
Q1 2010 $33M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.